European experts caring for young patients with a specific type of brain cancer have – for the first time – agreed and published freely-available guidance outlining how best to treat them.
An enzyme inspired by brain cancer DNA that has the potential to slash greenhouse gas emissions from the production of nylon won the 2024 Cambridge Climate Challenge.
The University of Cambridge’s Early Cancer Institute – the UK's only research facility dedicated to understanding early cancer – has received a landmark £11 million donation to support its vital work in the fight against cancer.
Researchers at the University of Cambridge have created the world’s largest catalogue of human breast cells, which has revealed early cell changes in healthy carriers of BRCA1 and BRCA2 gene mutations.
A person’s microbiome can aid treatment for multiple different cancer types, allowing researchers to develop microbial tests or treatments to help support immunotherapy in the future.
A new test to help diagnose a condition that can lead to oesophageal cancer – developed by Cambridge researchers and trialled by the NHS – has reduced the need for invasive endoscopy in thousands of low-risk patients.
Professor Sir Stephen Jackson, Professor Richard Gilbertson, Professor Rebecca Fitzgerald and Professor Greg Hannon have joined forces with Cancer Research UK to call on philanthropists to help tackle the disease.